PEDIATRICS Vol. 89 No. 5 May 1992, pp. 819-821
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VALAES, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VALAES, T.

Bilirubin Toxicity: The Problem Was Solved a Generation Ago

TIMOS VALAES MD, DCH1

1 Dept of Pediatrics, Tufts University School of Medicine, Division of Newborn Medicine, New England Medical Center Hospital, Boston, MA 02111

The article by Newman and Maisels1 in the current issue of Pediatrics is the latest in their crusade to prove that the prevailing management of neonatal jaundice is of unproven efficacy, probably risky, definitely wasteful of resources, and, therefore, should be changed.2-6 There is no doubt that the status of neonatal jaundice has been reduced to that of an "expensive nuisance." It is very common, but, in the great majority of the cases, it is not accompanied by any other clinical or laboratory abnormality, has no diagnostic value, and disappears in a few days without sequelae. The current status of neonatal jaundice contrasts with the respect and fear it generated in the past.

Submitted on September 6, 1991
Accepted on October 16, 1991




This article has been cited by other articles:


Home page
 J Child NeurolHome page
V. Wong, W.-X. Chen, and K.-Y. Wong
Short- and Long-Term Outcome of Severe Neonatal Nonhemolytic Hyperbilirubinemia
J Child Neurol, April 1, 2006; 21(4): 309 - 315.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. F. Watchko
Vigintiphobia Revisited
Pediatrics, June 1, 2005; 115(6): 1747 - 1753.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
V. K. Bhutani, G. R. Gourley, S. Adler, B. Kreamer, C. Dalin, and L. H. Johnson
Noninvasive Measurement of Total Serum Bilirubin in a Multiracial Predischarge Newborn Population to Assess the Risk of Severe Hyperbilirubinemia
Pediatrics, August 1, 2000; 106(2): 17e - 17.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. B. Newman and M. J. Maisels
Less Aggressive Treatment of Neonatal Jaundice and Reports of Kernicterus: Lessons About Practice Guidelines
Pediatrics, January 1, 2000; 105(1): 242 - 245.
[Abstract] [Full Text]

Home page
 PediatricsHome page
V. K. Bhutani, L. Johnson, and E. M. Sivieri
Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns
Pediatrics, January 1, 1999; 103(1): 6 - 14.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
T. W. R. Hansen
Therapeutic Approaches to Neonatal Jaundice: An International Survey
Clinical Pediatrics, June 1, 1996; 35(6): 309 - 316.
[Abstract] [PDF]